As soon as Marit's speech ended, everyone at the scene looked at each other and then bombarded.

There are all things to say, but no one can say that Marit's remarks are wrong, because he is correct and naturally stands on the moral side.

Indeed, this drug is expensive and cannot be used by ordinary people. So how can you do an organ transplant? This will be an important constraint.

The key is that Marit is from the perspective of all mankind and hopes that Pumpkin Vine Pharmaceutical Company can transfer relevant drug patents. This view is also in line with the political propositions of mainstream "white left" in Europe and the United States.

So foreign doctors immediately applauded, and the applause supported Professor Marit, that is, those who applauded support for patents that should not be controlled by a few companies, but should be contributed.

Of course, it is unknown how much there is sincere support, and how many it is arranged by Marit.

But at least in public, it is absolutely impossible to refute that publicly appeals not to make patents a tool for a few companies to make profits.

When Marite saw the reaction at the scene, he also smiled slightly.

He is a professor, hospital dean, and university vice president, but these identities are not enough. How to exchange identities for money is the key.

The reason why Maritt came uninvited was that he wanted to take the initiative in these two transplant surgeries, and even asked for the transfer of patents in the name of the International Organ Transplant Association.

All this comes from the father behind him, Johnson.

Johnson is the second largest pharmaceutical company in the Mold Country after Pfizer Pharmaceuticals. Even Lilai Pharmaceuticals can only rank behind them.

Chen Xia had created so many drugs for the digestive, respiratory and endocrine systems before, but only cooperated with Pfizer, which also led to Pfizer's tendency to become the dominant one in the moldy country.

This is something that Johnson and Lilai Pharmaceutical cannot tolerate, and they must stop it.

This is also the reason why Lilai Pharmaceutical initially wanted to forcibly copy atomized drugs regardless of the patent protection law.

The good show that Professor Marit today was actually behind Johnson & Johnson.

Every pharmaceutical company has its own flagship products. For example, Johnson & Johnson's medical devices have always been ranked high and are also "good friends" of many surgeons.

The promotion of organ transplantation is also indispensable for sponsorship from these pharmaceutical companies. Pharmaceutical companies also hope that the more surgeries the doctor can have, the better. In this way, the more surgical machinery is consumed, the higher the sales and profits of pharmaceutical companies will be.

This is a natural interest group.

Dr. Marit is not a white lotus. As a top expert in the field of surgery, he has a close relationship with Johnson Pharmaceuticals. To put it bluntly, he is just a pawn of capital.

This time I heard that Pumpkin Vine Pharmaceutical Company in Xiangjiang has invented anti-rejection drugs and will conduct teaching operations and clinical experiments in China.

Johnson immediately sent Professor Marit to participate in this teaching operation as an official capacity, and suddenly took the initiative in the operation in the name of the association's chairman.

The same is true for this analysis of the disease.

Then it is difficult to publicly publish it at this meeting, so I bluntly demand that the patent rights be taken over to the association.

This is a very good time, although it is not a formal, global, official academic conference on organ transplantation.

But now sitting in the audience almost caught all the surgeons engaged in organ transplant work around the world.

There are nothing more than the doctors from Hua and Xiangjiang. According to previous levels, doctors from these two regions are not qualified to participate.

Now Yuezhou Hospital, or Chen Xia, is facing an embarrassing problem.

It would be fine if he agreed to Marit's request. Although he would suffer significant economic losses, at least he would be a good reputation and a selfless person.

But what if he refuses?

There is a rule in the international medical community, which is that if you want to promote a new technology, new invention, new drugs, and new techniques, you must first get the recognition of the industry association.

This recognition represents the recognition of the mainstream medical community in the international world, so that it can be market-oriented and transformed into profits.

Don’t underestimate the recognition of this association. This is an important sign that whether these new drugs can enter developed countries in Europe and the United States.

In European and American countries, the opinions of a professional association can indirectly represent official opinions.

Because politicians do not understand these professional knowledge, they need industry associations to determine whether good or bad, whether reasonable or unreasonable.

This also gives these industry associations great rights. Being recognized by the association is "mainstream" and not being recognized by the association is "non-mainstream". It's that simple.
Chapter completed!